## FDX: FedEx Corporation - XLI: Industrials

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.9% in lower entry zone (3.0-6.0%), top quartile (78th pct) cross-sectional ranking. Short-term MRS_5 (3.4%) confirms momentum alignment. Strong momentum (+4.1% 5-day acceleration). Caution: overbought RSI (77).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($295.89)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. FedEx Corp presenta los resultados del trimestre finalizado el 31 de mayo - Resumen de resultados**
- Source: TradingView â€“ Acompanhe todos os mercados | 20260106T160757 | Bullish | Relevance: 100%
- FedEx Corp reported adjusted quarterly earnings of $6.07 per share for the quarter ending May 31, surpassing analysts' average estimate of $5.81 per share. Revenues also exceeded expectations, rising 0.5% year-over-year to $22.22 billion against an anticipated $21.79 billion. Despite these positive results, FedEx shares have declined 6.0% this quarter and 18.5% year-to-date.

**2. FedEx stock hits 52-week high at $297.08**
- Source: Investing.com | 20260105T103300 | Bullish | Relevance: 100%
- FedEx stock reached a new 52-week high of $297.08, reflecting a 9.35% increase over the past year and a 22.92% return in the last six months. This surge is attributed to increased demand for shipping and logistics, strong Q2 fiscal results, and strategic initiatives including an AI education program. Despite this, InvestingPro analysis suggests the stock might be slightly overvalued.

**3. North Growth Management Ltd. Decreases Stock Position in FedEx Corporation $FDX**
- Source: MarketBeat | 20260104T130754 | Somewhat-Bullish | Relevance: 100%
- North Growth Management Ltd. reduced its holdings in FedEx (NYSE:FDX) by 17.6% in the third quarter, offloading 6,000 shares to hold 28,000 shares valued at approximately $6.706 million. This trimming occurred despite FedEx reporting stronger-than-expected Q4 results with $4.82 EPS and analysts maintaining a "Moderate Buy" rating with an average target price of $298.92. The company also declared a quarterly dividend of $1.45 per share, offering a 2.0% yield.

**4. 5 Core Stocks to Buy and Hold in 2026**
- Source: Morningstar | 20260105T210910 | Somewhat-Bullish | Relevance: 83%
- Morningstar experts David Sekera and Susan Dziubinski recap 2025 and preview 2026 on "The Morning Filter" podcast, discussing specific stock picks like Constellation Brands and Micron Technology, and reviewing Darden Restaurants and FedEx. They also delve into the obesity drug market, comparing Novo Nordisk and Eli Lilly. The episode concludes with a look at five core stocks recommended for the new year.

**5. New Report Helps Companies Meet and Exceed Requirements to Eliminate Human Trafficking from Supply Chains**
- Source: CSRwire | 20260104T190935 | Somewhat-Bullish | Relevance: 71%
- The Alliance to End Slavery and Trafficking (ATEST) has released a new report, "Beyond SB 657," providing guidelines for companies to prevent forced labor in their supply chains, particularly those complying with California's Transparency in Supply Chains Act. This report aims to help businesses meet and exceed regulatory requirements, setting a model for modern sourcing practices. ATEST emphasizes the importance of these efforts given California's significant economic influence and the potential to impact global human trafficking.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 14, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Citigroup | $327 | $310 | +5% |
| 2025-12-19 | Truist Securiti | $330 | $285 | +16% |
| 2025-12-19 | Morgan Stanley | $210 | $200 | +5% |
| 2025-12-19 | BMO Capital | $290 | $265 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Citigroup | main | Buy |
| 2025-12-19 | Truist Securiti | main | Buy |
| 2025-12-19 | Morgan Stanley | main | Underweight |
| 2025-12-19 | BMO Capital | main | Market Perform |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.0% (+13.2%)
- Blackrock Inc.: 7.2% (-2.5%)
- Dodge & Cox Inc.: 6.9% (+12.0%)
- Primecap Management : 4.0% (-6.4%)
- State Street Corpora: 3.9% (-2.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 14 raises (avg +8%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +4.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.27 suggests fair value with growth premium. Forward P/E 14.5x attractive for 15% earnings growth. Balance sheet: $1.2B free cash flow. Analyst sentiment positive (14 raises, avg +8%). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $72.7B |
| Beta | 1.36 |
| 52W Range | $194.30 - $308.10 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.27 |
| Forward P/E | 14.5 |
| Current P/E | 16.7 |
| YoY Growth | 14.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.2% to 3.9% (+4.1% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 78th percentile. MRS_5 at 3.4% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 77, risk of mean reversion. OFD pattern: +F0H (Breakout).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.90% (CS: 78) | Strong |
| RSI_14 | 77.2 | Overbought |
| MACD Histogram | 0.40 | Bullish |
| vs SMA20 | 1.066x | Above |
| vs SMA50 | 1.128x | Above |
| vs SMA200 | 1.290x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $307.91
- **Stop Loss:** $295.89 (3.9% risk)
- **Target:** $325.94 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 109
- **Position Value:** $33,562.19
- **Portfolio %:** 33.56%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $4.11 | $4.82 | +17.2% |
| 2025Q3 | $3.61 | $3.83 | +6.0% |
| 2025Q2 | $5.80 | $6.07 | +4.6% |
| 2025Q1 | $4.62 | $4.51 | -2.4% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_10*